the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients

Multicenter Retrospective Study Evaluating the Impact of Early Palliative Care on the Survival of Patients With Locally Advanced and / or Metastatic Cholangiocarcinoma (CCK)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04415190

Enrollment

150

Registered

2020-06-04

Start date

2020-06-01

Completion date

2020-12-31

Last updated

2020-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholangiocarcinoma

Brief summary

The prognosis for cholangiocarcinoma is bad. Potentially, early management by a palliative care team could increase overall survival. We will also assess whether early management by a palliative care team could impact progression-free survival, the place of death and the date of the last chemotherapy, in particular to avoid unnecessary chemotherapy cures in an imminent end of life

Interventions

OTHERearly palliative care

early palliative care

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age\> 18 years old * intra- or extra-hepatic CCK or histologically proven vesicular adenocarcinoma * Locally advanced and / or metastatic disease from the start or recurrent * Initial diagnosis or recurrence between 1/01/2013 and 31/12/2019

Exclusion criteria

* \<18 years old * death less than one week after the diagnostic

Design outcomes

Primary

Measure	Time frame	Description
Global survival	baseline	Global survival from the diagnosis (to the death or because of lost to follow up)

Countries

France

Contacts

Primary ContactAnthony Lopez

a.lopez@chru-nancy.fr0383858585

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026